BeStock  
Stocks › Biotechnology › PHAT

Phathom Pharmaceuticals PHAT

US equityMarket cap rank #3679Biotechnology
$6.81 +$0.03 (+0.44%)
Market closed · Oct 8, 7:20 am ET · Last extended-hours $6.80 -0.15%
Open$6.87
Prev close$6.78
Day range$6.60 – $7.03
Volume1.63M
Market cap$550.94M
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-5.4x
CheapRich

Near the bottom of its 5-year range · 6th percentile, 5-year average -2.4x

Price / book-1.6x
CheapRich

Above its usual level · 74th percentile, 5-year average -5.7x

Price / sales2.3x
CheapRich

Around its usual level · 49th percentile, 5-year average 50.0x

#2654 of 5146 stocks by PS (1 = cheapest)

P/E over five years

-8x-5x-2x1xOct '21Apr '24Oct '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$10.25
Price vs. fair value-33.6%Trading below the estimate
Star rating★★★★☆
Economic moatNone
UncertaintyHigh
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB -1.60 – -5.69 74% (pricier than usual) –
PE -5.45 -28.99 -2.37 6% (cheaper than usual) –
PS 2.30 1.39 50.02 49% (cheaper than usual) #2654 of 5146 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Morningstar view

Star rating★★★★
Fair value estimate$10.25
Economic moatNone
UncertaintyHigh

Discussion

No comments yet — be the first to weigh in on PHAT.

Leave a comment

Scroll to Top